Study of the effects of two eyedrops, Nepafenac and Flurbiprofen in reducing pain and inflammation in patients who are undergoing cataract surgery.
Phase 4
- Conditions
- Health Condition 1: null- Uncomplicated cataract patients undergoing phacoemulsification/small incision cataract surgery fulfilling the inclusion/exclusion criteria will be enrolled in the study.
- Registration Number
- CTRI/2017/01/007737
- Lead Sponsor
- Dr Saiyadali Allisabanavar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
1.Patients willing to give written informed consent.
2.Patients undergoing uncomplicated cataract surgery
Exclusion Criteria
1.Surgeries other than phacoemulsification/small incisional cataract surgery.
2.Known sensitivity to any of the ingredients in the study medications.
3.Patients with preexisting ocular pathology, inflammation, tumor and glaucoma.
4.History of previous intraocular surgery, uveitis and iritis or intraocular inflammation in the study eye.
5.Use of steroids and Non steroidal inflammatory drugs by systemic route within the 14 days of surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Measuring percentage reduction in pain and is assessed by Visual analogue scale and Anterior Chamber Cells and flare by The Sun Working Group Grading Scheme .Timepoint: one week
- Secondary Outcome Measures
Name Time Method Conjunctival redness by conjunctival hyperemia score and lid edema by Lid edema scoringTimepoint: one week